A detailed history of Aigh Capital Management LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Aigh Capital Management LLC holds 2,574,846 shares of XERS stock, worth $9.24 Million. This represents 3.53% of its overall portfolio holdings.

Number of Shares
2,574,846
Previous 2,185,654 17.81%
Holding current value
$9.24 Million
Previous $6.23 Million 40.12%
% of portfolio
3.53%
Previous 2.52%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$2.78 - $3.73 $1.08 Million - $1.45 Million
389,192 Added 17.81%
2,574,846 $8.73 Million
Q3 2024

Nov 13, 2024

BUY
$2.06 - $2.96 $4.5 Million - $6.47 Million
2,185,654 New
2,185,654 $6.23 Million

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $488M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Aigh Capital Management LLC Portfolio

Follow Aigh Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aigh Capital Management LLC with notifications on news.